Bauman, J. E., Duvvuri, U., Thomas, S., Gooding, W. E., Clump, D. A., Karlovits, B., . . . Argiris, A. (2018). Phase 1 Study of EGFR-Antisense DNA, Cetuximab, and Radiotherapy in Head and Neck Cancer With Preclinical Correlatives. Cancer.
シカゴスタイル引用形Bauman, Julie E., et al. "Phase 1 Study of EGFR-Antisense DNA, Cetuximab, and Radiotherapy in Head and Neck Cancer With Preclinical Correlatives." Cancer 2018.
MLA引用形式Bauman, Julie E., et al. "Phase 1 Study of EGFR-Antisense DNA, Cetuximab, and Radiotherapy in Head and Neck Cancer With Preclinical Correlatives." Cancer 2018.
警告: この引用は必ずしも正確ではありません.